How Technology Can Make or Break Your Acquisition Strategy in 2023 with Matt Rupprecht
Matt Rupprecht Featured in Heads Together Ep. 7 hosted by ActivateStaff CEO Rohan Jacob
Amidst the uncertainty of the current transactional landscape, leveraging technology can be a tremendous advantage for companies seeking a potential buyer. PMCF Director, Matt Rupprecht, shares his thoughts with ActivateStaff CEO, Rohan Jacob, on the impact of technology when formulating a transaction strategy.
In Episode 7 of ActivateStaff’s “Heads Together” series, Rupprecht and Jacob discuss the evolving market landscape of 2023 in the context of staffing agencies. The episode delves into how technology can increase the saleability of a staffing business, the power of process improvement through technology, and the hidden potential of tech-driven data in successful acquisitions.
More Articles
Distributors See Improving M&A Opportunity In 2026
After a year defined by uneven activity and macro uncertainty, M&A momentum enters 2026 with improving financing conditions, renewed buyer confidence, and substantial capital on the sidelines, creating a more constructive environment for well-positioned middle-market distributors.
HCM M&A Outlook 2026: AI, Specialization, and Global Shifts Shape Deal Flow
After years of volatility and transformation, the Human Capital Management (HCM) industry now finds itself navigating a landscape where geopolitical tensions and technological acceleration collide to create both unique challenges and new frontiers for growth.
Continued Momentum Drives Optimistic 2026 Plastics M&A Outlook
From transaction volume to EBITDA multiples, key indicators for plastics M&A are trending upward as 2026 begins, according to PMCF Investment Banking Managing Director John Hart.
The Long-Term Perspective: Insights from PMCF’s 30 Years in Middle-Market M&A
Thirty years ago, PMCF Investment Banking set out with a clear mission: to redefine how middle‑market businesses approach M&A.
2026 Medtech M&A Outlook Strengthens as Buyers Prioritize Innovation and Resilience
Medtech is entering 2026 with a healthier M&A environment supported by improved financing conditions, resilient sector performance, and a more straightforward path for strategic buyers and private equity.